Molina Healthcare of Illinois (MHIL) on March 2 announced the implementation of a new DME Navigator program for all lines of business effective June 1, 2026.
At a time when global geopolitical uncertainties continue to hit Liquified Petroleum Gas (LPG) supply, scientists at the Birla Institute of Technology and Science (BITS) Pilani, Hyderabad, have ...
Weeping Peninsula (South Limgrave) - Dungeons, Points of Interest, and Secrets East Liurnia - Dungeons, Points of Interest, and Secrets North Liurnia - Dungeons, Points of Interest, and Secrets West ...
India is examining the use of dimethyl ether (DME) as a possible substitute for liquefied petroleum gas (LPG) as global oil and gas market disruptions and geopolitical tensions raise concerns over ...
Amidst global energy supply concerns, Indian researchers have developed dimethyl ether (DME) technology, offering a promising indigenous alternative to LPG for cooking fuel and reducing India's import ...
Brandi Jones has over two decades of experience as a nurse in an acute care setting. Her clinical background includes pediatrics, medical-surgical, and women's health. She also specializes in ...
The global durable medical equipment (DME) market is expected to grow at a steady rate of 5–7% over the next five years, driven by demographic shifts, evolving healthcare needs, and rapid ...
LEHI, Utah--(BUSINESS WIRE)--Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, today announced a new strategic partnership with PromptCare, a leading ...
Please provide your email address to receive an email when new articles are posted on . The integration of second-generation anti-vascular endothelial growth factor (VEGF) therapies into treatment ...
Vor Biopharma (VOR) rose ~17% on Tuesday after J.P. Morgan initiated its coverage with an Overweight recommendation and a Dec. 2026 price target of $43, citing a potential blockbuster status for the ...
Today, the durable medical equipment management (DME) process can be fragmented, inefficient, and unreliable - leading to errors and delays that impact member health, inflate costs for health plans, ...
Shares of Vor Bio (Nasdaq: NASDAQ:VOR) rose after it reported that its partner, RemeGen (OTCPK:REGMF), met the main goal in a late-stage trial in China evaluating telitacicept for treating Sjögren’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results